Synerkine pharma

Synerkine Pharma focuses on developing novel fusion proteins that combine the immunomodulatory activities of different cytokines for the treatment of inflammatory, neuropathic, and osteoarthritic pain. The company's proteins target universal regulatory mechanisms in various types of chronic pain and possess unique properties that enable effective pain relief in multiple preclinical models.